This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Russell Louis Quinn: Innovator in 3D Vascularized Human Ocular Tissue
Introduction
Russell Louis Quinn is a notable inventor based in Washington, DC. He has made significant contributions to the field of biomedical engineering, particularly in the development of innovative solutions for ocular health. His work focuses on creating advanced tissue models that can aid in cell therapy and drug discovery.
Latest Patents
Quinn holds a patent for "3D vascularized human ocular tissue for cell therapy and drug discovery." This patent discloses methods for fabricating a three-dimensional engineered blood retinal barrier (BRB) that comprises choroid and retinal pigment epithelial cells. The techniques include the use of bioprinting, which allows for precise construction of the BRB. Additionally, the patent outlines the use of this engineered BRB for treating retinal degeneration and for screening purposes. A three-dimensional printing insert designed for bioprinting on a culture substrate sheet is also part of this innovative work.
Career Highlights
Russell Quinn is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His role at this prestigious institution allows him to contribute to groundbreaking research that has the potential to transform ocular therapies.
Collaborations
Quinn has collaborated with esteemed colleagues such as Kapil Bharti and Min Jae Song. These partnerships enhance the research efforts and broaden the impact of their collective work in the field of ocular health.
Conclusion
Russell Louis Quinn is a pioneering inventor whose work in 3D vascularized human ocular tissue is paving the way for advancements in cell therapy and drug discovery. His contributions are vital to the ongoing research in retinal health and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile